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ORIGINAL ARTICLE
The clinical characteristics of retinal vasculitis in
HLA-B27-positive patients*
Arthur Menno Braakenburg1 and Aniki Rothova2
1Department of Ophthalmology, VU University Medical Center Amsterdam, Amsterdam, Netherlands and
2Department of Ophthalmology, Erasmus Medical Center Rotterdam, Rotterdam, Netherlands
ABSTRACT
Purpose: To investigate the ocular and systemic manifestations of retinal vasculitis in HLA-B27-positive patients.
Methods: Retrospective noncomparative case series of 9 HLA-B27-positive patients with uveitis and retinal
vasculitis. Main outcome measures consisted of ocular and angiographic findings and assessment of any
additional systemic disorders.
Results: Three male and 6 female HLA-B27-positive patients with a median age of 32 years were diagnosed with
retinal vasculitis. Concurrent intraocular inflammation was noted in all patients. All patients suffered from
extensive vasculitis of the large retinal veins. Five patients developed retinal vasculitis at the onset of uveitis
and the remaining 4 exhibited retinal vasculitis 1–15 years after the onset of uveitis. Vascular occlusions
occurred in 4 patients and subsequent neovascularizations developed in 3. Three patients were diagnosed with
an HLA-B27-associated systemic disease.
Conclusion: Retinal vasculitis may develop in the wake of HLA-B27-associated uveitis and might represent a
rare manifestation of HLA-B27-associated disease.
Keywords: retinal, vasculitis, HLA-B27, ankylosing, spondylitis
HLA-B27-associated uveitis typically presents as a
recurrent unilateral acute anterior uveitis (AAU),1
although posterior segment manifestations in
HLA-B27-associated uveitis are regularly reported.2–4
The most common posterior segment manifestations
include vitritis, cystoid macular edema (CME), and
optic disc leakage.2–4 Occasional cases of retinal
vasculitis in HLA-B27-positive patients are also docu-
mented, and constitute about 20–25% of those with
posterior segment involvement.2,4–9 It is not known
whether the association of HLA-B27-antigen and
retinal vasculitis is coincidental or whether retinal
vasculitis might occur as a specific manifestation of an
HLA-B27-associated disease.
The aim of this study is to report on 9 HLA-
B27-positive patients with retinal vasculitis and
describe the clinical characteristics, fluorescein angio-
graphy (FA) findings, and visual outcomes.
MATERIAL AND METHODS
In this study we included 9 patients with retinal
vasculitis who were HLA-B27-positive. Five patients
were identified in the cohort of 177 HLA-B27-positive
patients presenting with typical AAU, sometimes
alternating, at the University Medical Center
Utrecht between 1995 and 2005. This data set included
10 (6%) patients with suspected retinal vasculitis
based on the basis of the presence of perivascular
sheathing and/or cuffing; however, fluorescein
angiographies met our inclusion criteria in only in
5 (3%) patients. The remaining 4 patients were
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selected from our database file of patients with retinal
vasculitis.
All patients underwent a standard screening
consisting of erythrocyte sedimentation rate, red and
white blood cell counts, determination of serum
angiotensin-converting enzyme levels, serologic test-
ing for syphilis and borreliosis, chest radiography,
and antinuclear antibody testing (ANA). In addition,
all patients were examined by a specialist in internal
medicine to assess the possible presence of associated
systemic disease. We identified 1 additional HLA-B27-
positive patient with retinal vasculitis who was
diagnosed with ankylosing spondylitis (AS) and
Crohn disease; however, this patient was excluded
from the present series since this association was
previously noted.10,11 Also, 1 HLA-B27-positive
patient with retinal vasculitis who also had a
biopsy-proven pulmonary sarcoidosis was excluded
from this our study.
In general, patients with retinal vasculitis are only
rarely typed for HLA-B27. In our center, only patients
with anterior uveitis and panuveitis are systematically
typed for HLA-B27, whereas patients with retinal
vasculitis who present mostly with posterior uveitis
are generally not typed for HLA-B27.
At present, there is no consensus on the definition
of retinal vasculitis.12 Therefore, for the purpose of
this study we adopted the following definition:
moderate to severe leakage of the large retinal vessels
during the middle and late FA frames and/or
occlusive retinal vasculopathy in the setting of
ocular inflammation. In the present study, the
presence of optic disc leakage, CME and slight
leakage, and/or late staining of the small retinal
vessels (capillaries) was in this study not considered
to indicate genuine retinal vasculitis, and, conse-
quently, these patients were not included. Also, slight
and local perivascular sheathing/cuffing alone was
not considered to be retinal vasculitis. The extension
of vasculitis was classified according to its location in
5 parts of the retina, specifically, the posterior pole
and four peripheral quadrants. All fluorescein angio-
grams were evaluated and coded by the 2 indepen-
dent ophthalmologists; in the case of whenever there
were differing evaluations, the angiograms were
discussed until an agreement on the diagnosis was
reached.
Multiple variables were assessed, such as age at
onset of ocular disease, systemic and ocular medical
history, and various clinical manifestations, including
severity, complications, treatment, and visual out-
comes. Systemic HLA-B27-associated diseases were
diagnosed according to standard diagnostic criteria.13
RESULTS
Information on the general data of 9 HLA-
B27-positive patients and their associated systemic
diseases is given in Table 1. The median age at onset
of retinal vasculitis was 32 years (range 17–52 years).
The median follow-up time from the onset of retinal
vasculitis was 5 years (range 6 months to 8 years).
Three patients were diagnosed with an HLA-
B27-associated systemic disease: 1 with AS, 1 with a
combination of juvenile idiopathic arthritis (JIA) and
psoriasis, and 1 with an undifferentiated spondylar-
thropathy. One additional patient was diagnosed with
palindromic rheumatism (Table 1). All of these
systemic disorders were manifest before the onset of
retinal vasculitis.
Retinal vasculitis did not occur as an isolated
phenomenon in any of our patients, but it always
developed with concurrent anterior or panuveitis.
Five patients had retinal vasculitis from the onset of
uveitis and in 4 of them it was preceded by a typical
TABLE 1. General characteristics of 9 human leukocyte antigen (HLA)-B27-positive patients with retinal vasculitis.
Patient no. Gender
Age at onset of
uveitis (years)
Age at onset
of RV (years) Systemic disease Treatment of RV
1 M 51 52 AS Systemic and periocular CS,
MTX, photocoagulation
2 M 20 20 None Periocular and systemic CS,
PPV, photocoagulation, AZA
3 F 33 33 None Periocular and systemic CS,
PPV
4 M 31 32 USPA Periocular CS
5 F 28 28 None Periocular CS
6 F 17 17 None Systemic CS
7 F 11 26 JIA, psoriasis Systemic and periocular CS,
AZA, CsA
8 F 28 35 Palindromic rheumatism Systemic and periocular CS,
MTX, photocoagulation
9 F 38 38 None Periocular CS, photocoagula-
tion, PPV
Note. M, male; F, female; AS, ankylosing spondylitis; AZA, azathioprine; CS, corticosteroids; CsA, cyclosporine A; MTX, methotrexate;
PPV, pars plana vitrectomy; RV, retinal vasculitis; USPA, undifferentiated spondylarthritis; JIA, juvenile idiopathic arthritis.
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acute anterior uveitis after which the retinal vasculitis
developed several years later (Table 1). Eight of our
9 patients (89%) had bilateral retinal vasculitis (in total
17 affected eyes; Table 2).
In all but 1 patient (patient 2, Table 1) the duration
of uveitis and retinal vasculitis was longer than
3 months. The exact duration of the retinal vasculitis
activity was difficult to assess, but in at least of the
9 patients active retinal vasculitis persisted even when
the uveitis became quiescent. Involvement of the large
veins was noted in all patients, whereas retinal
arteritis was not seen in any of the patients
(Figure 1). Peripheral retinal quadrants were involved
in all affected eyes, and in 5 patients (10/17; 59% of
the affected eyes) the vessels of the posterior pole
were also affected. In 5 patients (8/17; 47% of the
affected eyes) the retinal vasculitis was accompanied
by vascular occlusions and in 6 patients (10/17; 53%
of the affected eyes) by retinal ischemia. In 3 patients
(6/17; 35% of the affected eyes) neovascularizations
developed. Retinal hemorrhages were present in
6 patients (8/17; 47% of the affected eyes). Seven
patients (13/17; 76% of the affected eyes) developed
CME, and 7 patients (12/17; 71% of the affected eyes)
had optic disc leakage. Vitreous hemorrhages devel-
oped in 3 patients, 2 of whom them underwent a pars
plana vitrectomy (PPV). All vitreous hemorrhages
were in eyes with neovascularizations.










ischemia Neovascularization Onset RV 6-month FU 3-year FU
1 Right Yes PP, peripheral (4) No Yes Yes Yes 0.4 1.0 1.0
Left Yes PP, peripheral (4) No Yes Yes Yes 0.6 1.0 0.6
2 Right Yes PP, peripheral (2) Yes Yes Yes Yes 0.05 1.0 1.0
Left Yes PP, peripheral (1) Yes Yes Yes Yes 1.2 1.0 1.0
3 Right Yes Peripheral (4) Yes Yes Yes No 0.8 0.8 1.0
Left Yes Peripheral (3) Yes Yes Yes No 0.5 0.8 0.8
4 Right Yes Peripheral (2) Yes Yes No No 1.2 1.0 1.0
Left Yes Peripheral (2) Yes Yes No No 1.0 1.0 1.0
5 Right No NA NA NA NA NA NA NA NA
Left Yes Peripheral (2) Yes Yes Yes No 0.16 0.8 NA
6 Right Yes PP, peripheral (3) Yes No No No 0.63 1.0 1.0
Left Yes PP, peripheral (2) Yes No No No 0.8 1.0 1.0
7 Right Yes PP, peripheral (2) Yes Yes No No 0.3 0.4 1.0
Left Yes PP, peripheral (4) Yes Yes No No 0.4 0.6 0.7
8 Right Yes PP, peripheral (2) Yes Yes Yes No 0.2 0.5a NA
Left Yes PP, peripheral (2) No Yes No No 1.0 0.3a NA
9 Right Yes Peripheral (3) No No Yes Yes 1.0 1.0 1.0
Left Yes Peripheral (3) No No Yes Yes 0.5 0.5 0.5b
Total 17 (94%) 12 (71%) 13 (76%) 10 (59%) 6 (35%)
Note. CME, cystoid macular edema; FU, follow-up; NA, not applicable; PP, posterior pole; RV, retinal vasculitis.
aLoss of vision caused by CME.
bTemporary low vision caused by cataract.
FIGURE 1. (A) Retinal vasculitis, optic disc leakage and cystoid macular edema in a 26-year-old HLA-B27-positive female patient
with recurrent attacks of anterior uveitis from 11 years of age, juvenile idiopathic arthritis and psoriasis (Table 1 and 2, patient no. 7).
(B) Mild optic disc leakage and not yet regressed neovascular membrane above the optic disc following the partial panlaser
photocoagulation and treatment with systemic steroids and methotrexate in a 52-year-old HLA-B27-positive patient with ankylosing
spondylitis and previous attacks of acute anterior uveitis (Table 1 and 2, patient no. 1). Note the irregular vascular walls and the
residual staining of the veins in the perimacular region. (C) The opposite eye of the same patient (no. 1) exhibiting leakage of the big
retinal veins on the late frames of fluorescein angiography.
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Treatment of retinal vasculitis is shown in Table 1.
In 5 patients, (including 1 who also received periph-
eral photocoagulation), the uveitis and retinal vascu-
litis reacted well to systemic and/or periocular
steroids. In 4 patients the retinal vasculitis and/or
uveitis became steroid-resistant and additional immu-
nosuppressive medications, such as cyclosporine A,
methotrexate (MTX), and/or azathioprine, were
required. Of these 4 patients, 1 was diagnosed with
AS, 1 with a combination of JIA and psoriasis, 1 with
palindromic rheumatism, and in 1 patient no systemic
disease was found. The JIA patient suffered from
arthritis and, initially, from alternating unilateral
AAU attacks; she was negative for ANA, but positive
for HLA-B27. Four patients received photocoagula-
tion and 3 underwent PPV.
At the onset of retinal vasculitis, 5 patients (6/17;
35% affected eyes) had a visual acuity of less than 0.5.
At 6 months follow-up, 2 patients had with a visual
acuity of less than 0.5, both unilateral. At 3-year
follow-up, none of the 7 followed patients had a
visual acuity of less than 0.5.
SELECTED CASE: PATIENT 1
A 52-year-old HLA-B27-positive male was referred to
our institute with retinal vasculitis in the right eye,
which developed approximately 1 year after recurrent
attacks of alternating AAU, which had now pro-
gressed to panuveitis and development of retinal
vasculitis. Medical history revealed that he developed
AS at age 27 years. Three months after the onset of
vasculitis in the right eye, retinal vasculitis progressed
to bilateral involvement. FA revealed a retinal
vasculitis of the central and peripheral veins asso-
ciated with retinal hemorrhages, vascular occlusions,
and development of neovascularizations, optic disc
leakage, and CME (Figure 1). Subsequently, the
patient developed recurrent vitreous hemorrhages
in the right eye. In addition to local treatment,
the patient received periocular steroid injections,
systemic steroids (initial dose 60 mg), and MTX (initial
dose 10 mg/week) with the addition of folic acid.
Inflammation of the anterior segment and the vitreous
subsided within 2 months. In the following months,
panretinal photocoagulation was performed in both
eyes. After this treatment, FA revealed a mild
activity of retinal vasculitis in both eyes with optic
disc leakage and decreased neovascularizations.
The uveitis in both eyes was quiescent and the
systemic corticosteroids were gradually reduced.
Three years later the patient developed a recurrence
of active bilateral occlusive retinal vasculitis compli-
cated by CME, despite the ongoing treatment
with MTX. Periocular steroids were added and retinal
vasculitis activity slowly decreased. Four years
after the onset of retinal vasculitis the patient is still
on MTX and his visual acuity is 1.0 in the right eye
and 0.6 in the left eye.
DISCUSSION
In a cohort of 177 HLA-B27-positive patients initially
presenting with anterior uveitis, we identified retinal
vasculitis in 5 (3%) patients and identified an
additional 4 more HLA-B27-positive patients among
those the patients with retinal vasculitis. All HLA-
B27-positive retinal vasculitis patients had concurrent
panuveitis and 4 had previous AAU attacks typical
for HLA-B27-associated uveitis. The most common
FA findings included extensive phlebitis, which was
in most cases associated with optic disc leakage
and CME. Although 4 patients became steroid-
resistant and 3 developed neovascularizations with
vitreous hemorrhages, in all followed patients the
visual acuity at the 3-year follow-up was 0.5 or
better.
The association between retinal vasculitis and
HLA-B27 might be a coincidence, but might also
represent a true, but rare association where retinal
vasculitis forms a part of an HLA-B27-associated
disorder. In our series, 4 of the patients had previous
attacks of AAU, typical for HLA-B27-associated
uveitis, and 3 patients (patients 1, 4 and 7 in
Table 1) suffered from systemic diseases known to
be linked to the HLA-B27 antigen.1 No additional
causes or explanations for retinal vasculitis were
found in our patients. These findings support the
hypothesis that retinal vasculitis might occur in the
wake of an HLA-B27-associated disorder. Several
reports on retinal vasculitis in HLA-B27-positive
patients were previously published and were con-
sidered a part of atypical posterior segment manifes-
tations in HLA-B27-associated uveitis.2,4–9 From a
cohort of 166 patients with HLA-B27-associated
uveitis, Rodriguez et al. reported 7 (4%) patients
with retinal vasculitis, which is in accordance with
our findings.4 The occurrence of retinal vasculitis in
HLA-B27-associated disease may in fact even be
higher than 3%, as not all our patients with retinal
vasculitis were tested for HLA-B27. Furthermore, if all
patients with HLA-B27-associated uveitis underwent
FA the percentage might be higher, as retinal
vasculitis can be missed if based on fundoscopic
examination alone. However, approximately 8% of the
people in Western Europe are HLA-B27-positive14 and
certainly in some cases the association between retinal
vasculitis and the HLA-B27 antigen might be
coincidental.
Multiple reports were published on retinal
vasculitis occurring in Crohn disease, where retinal
vasculitis probably represents a rare complication
of this systemic disorder.10,11 One of our retinal
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vasculitis patients was diagnosed with both Crohn
disease and AS.
An interesting question is whether retinal vasculitis
in HLA-B27-positive patients is confined to the eyes
or might merely represent merely a symptom of a
generalized vasculitis. There are multiple reports of
aortic arteritis, polyarteritis nodosa, and Takayasu
arteritis in HLA-B27-positive individuals or in
patients with an already established HLA-
B27-associated disorder.15–17 In our patients, no overt
signs of systemic vasculitis were noted. Future
research might include a systematic search for
systemic vasculitis in affected patients.
Our cohort shared many of the clinical character-
istics with the HLA-B27-positive AAU population,
specifically the young age at onset, associated
systemic diseases, and a favorable visual prognosis.1
The only exception was a slight female preponderance
in contrast to the HLA-B27-associated AAU popula-
tion.1 It is possible that females with HLA-
B27-associated uveitis are more prone to atypical
ocular presentations, similar to other HLA-B27-asso-
ciated systemic disorders, such as AS.3,6,18,19 Although
HLA-B27-associated uveitis is generally of the acute
type located in the anterior eye segment, the uveitis
associated with retinal vasculitis was always panu-
veitis with generally a duration longer than 3 months.
Of our 9 HLA-B27-positive patients with retinal
vasculitis, 3 (33%) HLA-B27-positive patients with
retinal vasculitis developed neovascularizations,
which is higher than the approximately 15% found
in other retinal vasculitis types.8,20 The majority of our
patients with retinal vasculitis developed CME (63%),
which is consistent with previous findings in idio-
pathic retinal and retinal vasculitis in Behc¸et patients.8
Until now, less than 35 HLA-B27-positive patients
with retinal vasculitis have been reported.2,4–9
However, these patients were not thoroughly studied
and their clinical and FA characteristics were not well
described. Although Yalc¸indag et al. published a case
report on occlusive retinal vasculitis in an HLA-
B27-positive patient, in other cohorts no retinal
vascular occlusions or the development of neovascu-
larizations were found in their cohort of patients.2,8,9
In the present study, a problem during follow-up was
the assessment of the duration of retinal vasculitis
activity. FA was not regularly performed and the
fundoscopy was not always reliable. Of our 9 patients,
3 FA demonstrated extended retinal vasculitis, which
was not suspected on fundoscopic findings.
In general, the visual outcome of retinal vasculitis
depends on the underlying cause, the presence of
ischemia, and the treatment given. Despite the
relatively high number of complications, such as
retinal ischemia and the development of neovascular-
izations, in our series the visual prognosis was
favorable as none of the 7 patients who completed
3-year follow-up had developed visual acuity of less
than 0.5; however, we did lose 2 patients during the
follow-up period.
Our study has all the shortcomings of a retro-
spective study and lacks comparison with retinal
vasculitis in HLA-B27-negative patients. None of the
patients had indications of any other causes of retinal
vasculitis, although these might develop in the future.
In addition, we cannot report on the exact prevalence
of vasculitis in HLA-B27-associated uveitis. To answer
the question of whether retinal vasculitis is more
prevalent in HLA-B27-positive individuals compared
to their HLA-B27-negative counterparts would
require a large prospective study in which all patients
presenting with retinal vasculitis are were typed for
HLA-B27.
In conclusion, our study shows that, in this small
cohort, the finding of retinal vasculitis with panuveitis
may occur in the wake of HLA-B27-associated
disorders and may represent an infrequent manifesta-
tion of HLA-B27-associated ocular disease.
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